BMS-955176

DB15193InvestigationalSmall molecule

BMS-955176 is under investigation in clinical trial NCT02415595 (Dose-finding Study of BMS-955176 to Treat HIV-1 Infected Treatment-naive Adults).

Chemical structure of BMS-955176
Mechanism
Curator reviewed
Formula / weight
C42H62N2O4S · 691.03 g/mol (avg)
Code names
BMS-955176

Resolves to

Compound
UNII4CA9IAU7RJCAS1392312-45-6ChEMBLCHEMBL3827379
Structure
InChIKeyXDMUFNNPLXHNKA-ZTESCHFWSA-NSMILESCC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC=C(C6=CC=C(C=C6)C(O)=O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)NCCN1CCS(=O)(=O)CC1
Targets
Q72497gag

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
5Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with BMS-955176, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In